These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16619511)

  • 1. Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy.
    Hambek M; Werner C; Baghi M; Gstöttner W; Knecht R
    Anticancer Res; 2006; 26(2A):1091-5. PubMed ID: 16619511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.
    Hambek M; Werner C; Baghi M; Gstöttner W; Knecht R
    Eur J Cancer; 2007 Jul; 43(10):1502-7. PubMed ID: 17524637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
    Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.
    Ijichi K; Adachi M; Hasegawa Y; Ogawa T; Nakamura H; Kudoh A; Yasui Y; Murakami S; Ishizaki K
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):745-52. PubMed ID: 18075740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.
    Li D; Ronson B; Guo M; Liu S; Bishop JS; Van Echo DA; O'Malley BW
    Cancer Res; 2002 Jul; 62(14):4023-8. PubMed ID: 12124336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor.
    Kavanagh BD; Lin PS; Chen P; Schmidt-Ullrich RK
    Clin Cancer Res; 1995 Dec; 1(12):1557-62. PubMed ID: 9815956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio.
    Marcu LG; Bezak E
    J Theor Biol; 2012 Mar; 297():41-7. PubMed ID: 22182756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma.
    Mace AT; Harrow SJ; Ganly I; Brown SM
    Acta Otolaryngol; 2007 Aug; 127(8):880-7. PubMed ID: 17763002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines.
    Czembirek C; Eder-Czembirek C; Erovic BM; Turhani D; Selzer E; Thurnher D
    Oncol Rep; 2005 Dec; 14(6):1523-6. PubMed ID: 16273249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor modifies cell cycle control in A431 human squamous carcinoma cells damaged by ionizing radiation.
    Laderoute KR; Ausserer WA; Knapp AM; Grant TD; Sutherland RM
    Cancer Res; 1994 Mar; 54(6):1407-11. PubMed ID: 8137238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
    Wang SJ; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cisplatin-induced apoptosis in laryngeal squamous cell carcinoma strain and the influence on cell cycle].
    Qi F; Zhang B; Xu Y
    Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):298-301. PubMed ID: 11601059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.